ChemoTherapy aNd chemoradioTherapy for adenocarcinoma of the OESophagus and esophagogastric junction with oligometastases: Protocol of the TNT-OES-1 trial

Background: FLOT and CROSS are effective neoadjuvant regimens for esophageal cancer patients. Chemotherapy (FLOT) is aimed to have merely a systemic effect whereas neoadjuvant chemoradiotherapy (CROSS) achieves good locoregional response with clinically complete response (cCR) rates up to 33% [1]. T...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Charlène J. van der Zijden, Ben M. Eyck, Ate van der Gaast, Leni van Doorn, Joost J.M.E. Nuyttens, J. Jan B. van Lanschot, Bas P.L. Wijnhoven, Bianca Mostert, Sjoerd M. Lagarde
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2022-08-01
coleção:	Contemporary Clinical Trials Communications
Assuntos:	Esophageal cancer Esophagogastric junction Adenocarcinoma Oligometastatic disease Chemotherapy Chemoradiotherapy
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2451865422000515
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!